RTW Biotech Opportunities Ltd USD (RTW.L) LSE

2.16

-0.02(-0.92%)

Updated at December 24 12:35PM

Currency In USD

Valuation

Market Cap455.64M
Enterprise Value545.44M
P/E Ratio-7.72
PEG Ratio0.02
Price/Sales Ratio20.1
Price/Book Ratio1.27
Enterprise/Revenue23.62
Enterprise/EBITDA-17.13

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-2.63
Operating Margin0.62

Management Effectiveness

Return On Assets-0.12
Return On Equity-0.16

Income Statement

Revenue43.5M
Revenue/Share0.11
Gross Profit38.73M
EBITDA38.89M
Net Income34.18M
Diluted EPS0.1

Balance Sheet

Total Cash2.66M
Total Cash/Share0.01
Total Debt126.3M
Total Debt/Equity0.23
Current Ratio1.26
Book Value Per Share1.77

Price History

52-Week Change51.05
52-Week High2.25
52-Week Low1.08
Moving Average 50 Days1.89
Moving Average 200 Days1.44

Statistics

Average Volume1.17M
Shares Outstanding326.62M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A